Researchers Developed Paper-Based Cholesterol Assay

A new platform utilizes specialized paper to improve the measurement of cholesterol efflux capacity in laboratory studies.

Updated on Oct. 13, 2026 in Nutrition

A close-up view of a droplet of liquid soaking into a piece of white filter paper in a laboratory setting.
Researchers have developed a paper-based assay platform that enhances the efficiency and precision of laboratory studies measuring cellular cholesterol efflux capacity. AI Illustration. Upload story photo >

Live Poll

Do you support the adoption of new, simplified laboratory testing methods in medical diagnostics?

Scientists have successfully created a paper-based platform for conducting cholesterol efflux capacity assays. This new method provides results that are comparable to traditional commercial techniques, offering a more efficient way to study cellular cholesterol.

Why it matters

Conventional 2D cell culture assays often fail to accurately mimic the complex microenvironment found in the human body. This advancement offers a more precise tool for researchers to evaluate how cells manage cholesterol levels, which is vital for understanding cardiovascular health.

The study involved 38 volunteers and confirmed the platform's accuracy using 100 nM phorbol 12-myristate 13-acetate for differentiation. Researchers used a 50 mM concentration of BODIPY-cholesterol to induce foam cell formation.

The players

THP-1

These are human monocytic cell lines derived from an acute monocytic leukemia patient that are widely used in biomedical research.

The details

The platform uses Whatman No. 1 paper as a membrane scaffold to hold differentiated THP-1 macrophages. Efflux capacity was calculated by measuring the percentage of BODIPY-cholesterol released from the cells, observed through fluorescence intensity at an excitation of 482 nm and an emission of 522 nm.

Timeline

  1. The research findings were published on October 13, 2026.

The Big Picture

This innovation provides a new methodological framework for lipid analysis that complements findings seen in the ORION-10 statin trial.

This diagnostic advancement provides scientists with more accurate tools for evaluating cellular health, potentially leading to better understanding of lipid-related conditions. While not an immediate change for patients, it improves the methodology used to develop future cardiovascular treatments.

The takeaway

This study demonstrates that simple membrane scaffolds can successfully replicate complex biological assays. Researchers looking for cost-effective alternatives in laboratory settings can implement this paper-based approach to standardize their cholesterol testing protocols.

Further reading

Learn more about the latest research in this field by visiting Nutrition.

More information

View the original peer-reviewed research article on the study's findings.

Source note: This article includes information reported by Nature.

Live Poll

Do you support the adoption of new, simplified laboratory testing methods in medical diagnostics?